Fanapanel, ZK-200775, MPQX
法那帕奈Chemical Name: 7-Morpholino-2,3-dioxo-6-(trifluoromethyl)-1,2,3,4-tetrahydroquinoxalin-1-ylmethylphosphonic acid
CAS No. 161605-73-8
项目整合开发状态: Phase I
项目研究机构: Novo Nordisk (Originator), Schering AG (Originator)
合成路线:The reaction of 2,4-dichloro-5-(trifluoromethyl)nitrobenzene (I) with aminomethanephosphonic acid (II) by means of NaOH in ethanol/water gives the anilinomethanephosphonic acid (III),which is condensed first with morpholine (IV) by heating at 120 C and esterified with triethyl orthoformate at 150 C yielding 5-(4-morpholinyl)-2-nitro-4-(trifluoromethyl)phenylaminomethyl phosphonic acid diethyl ester (V).The reduction of the nitro group of (V) with H2 over Pd/C in ethanol affords the corresponding amino-derivative (VI),which is cyclized with oxalic acid monoethyl ester monochloride (VII) by means of triethylamine in THF providing the quinoxaline (VIII).Finally,this compound is hydrolyzed to the free phosphonic acid with trimethylbromo silane in acetonitrile.
📌 参考资料/链接:
参考文献标题:Quinoxalindione derivs.,their preparation and their use in drugs
文献作者:Huth,A.; Turski,L.(Schering AG)
参考来源:DE 4314591; DE 4344486; EP 0696288; EP 1002796; JP 1996508037; US 5750525; WO 9425469